Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,24
KB-0,92
PKN66,9266,98-0,30
Msft396,11396,17-3,20
Nokia3,3843,43-0,69
IBM167,82167,88-8,82
Mercedes-Benz Group AG73,1473,16-1,08
PFE25,4225,43-3,30
25.04.2024 19:13:46
Indexy online
AD Index online
select
AD Index online
 

  • 25.04.2024 18:00:07
Krka DD (KRK.WA, Warsaw)
Poslední obchod Změna (%) Změna (PLN) Objem obchodů (PLN)
546,00 0,00 0,00 6 012
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 25.04.2024
Popis společnosti
Obecné informace
Název společnostiKrka d.d. Novo Mesto
TickerKRKG
Kmenové akcie:Ordinary Shares
RICKRKG.LJ
ISINSI0031102120
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky31.12.2023
Počet zaměstnanců k 31.12.2023 11 667
Akcie v oběhu k 31.12.2023 30 877 482
MěnaEUR
Kontaktní informace
UliceSmarjeska cesta 6
MěstoNOVO MESTO
PSČ8501
ZeměSlovenia
Kontatní osoba 
Funkce kontaktní osoby 
Telefon38 673 312 111
Fax38673321537

Business Summary: Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Krka d.d. Novo Mesto revenues increased 5% to EUR1.81B. Net income decreased 14% to EUR313.9M. Revenues reflect European Union segment increase of 11% to EUR1B, Other segment increase of 14% to EUR109.8M, South East Europe segment increase of 9% to EUR101.4M, West Europe segment increase of 13% to EUR369.6M, Central Europe segment increase of 9% to EUR397.1M.
Odvětvová klasifikace
TRBC2012Generic Pharmaceuticals
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSMedicinal and Botanical Manufacturing
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Medicinal & Botanical Mfg
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Medicinal and Botanical Manufacturing
SICPharmaceutical Preparations
SICMedicinals And Botanicals



  • Poslední aktualizace: 25.04.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman (President) of the Supervisory Board - Shareholders' RepresentativeJoze Mermal6827.07.201621.06.2015
Chief Executive Officer, Chairman (President) of the Management BoardJoze Colaric6701.01.200501.01.1993
Independent Vice Chairman (Deputy President) of the Supervisory Board - Shareholders' RepresentativeMatej Lahovnik5001.01.2020
Independent Vice Chairman (Deputy President) of the Supervisory Board - Employees' RepresentativeFranc Sasek5621.06.200921.06.2009
Member of the Management BoardDavid Bratoz4418.11.201518.11.2015
Member of the Management Board - Worker Director, Deputy Director of Pharmaceutical ProductionMilena Kastelic5228.09.2015
Member of the Management Board, Director of Pharmaceutical R&D and ProductionAles Rotar6201.01.2001
Member of the Management Board, Director of API R&D, Production and Supply ChainVinko Zupancic5101.01.201001.01.2010